Our CEO, Prof. Magdalena Król, recently had an exciting opportunity at the ESGCT 2023 conference. She had the privilege of presenting the “Macrophage-based Immunotherapy of Platinum-Resistant Ovarian Cancer” (MACOV) project to none other than the EIC Programme Manager, Iordanis Arzimanoglou.
This unique chance to showcase our groundbreaking project added a new dimension to the conference, and we are thrilled to be at the forefront of innovative solutions in cancer treatment. Stay tuned for more updates on this exciting development! 🌐🔬 #ESGCT2023 #CancerResearch #Innovation
